Johnson & Johnson (JNJ) Sees FY13 Revs at $70.4B - $71.1B; Est. at $71.1B
Tweet
Share
E-mailGet Alerts JNJ Hot Sheet
Price: $268.50 -2.45%
EPS Growth %: +3.6%
Financial Fact:
Earnings before provision for taxes on income: 5.28B
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: +3.6%
Financial Fact:
Earnings before provision for taxes on income: 5.28B
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Johnson & Johnson (NYSE: JNJ) sees FY13 sales of $70.4 billion to $71.1 billion. The Street is currently at about $71.1 billion.
Earlier, the
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
Earlier, the
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Johnson & Johnson to present neuropsychiatry data at Psych Congress 2026
- UiPath Inc. (PATH) Reports In-Line Q2 EPS; offers guidance
- Samsara Inc (IOT) Tops Q2 EPS by 4c, Beats on Revenue; Offers Q3 Guidance
Create E-mail Alert Related Categories
Guidance, Hot GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
